Mirjam Schenk

4.6k citations
38 papers · 3.0k indexed · h-index 26
Topics
Cancer Immunotherapy and Biomarkers (10 papers)Immune Response and Inflammation (10 papers)Immune Cell Function and Interaction (8 papers)

In The Last Decade

Mirjam Schenk

36 papers receiving 2.9k citations

Peers

Mirjam Schenk
Comparison fields: 5 of 114
  • Immunology 1.7k
  • Molecular Biology 771
  • Infectious Diseases 590
  • Oncology 539
  • Epidemiology 471
Replace Laura M. Sly with:
Laura M. Sly Canada
Hideki Iijima Japan
Jean Gosselin Canada
Yoshikazu Naiki Japan
Madeline Fort United States
Fang Shen United States
Markus Gerhard Germany
Edith M. Hessel United Kingdom
Joanne L. Viney United States
Harumichi Ishigame Japan
Mirjam Schenk relative to Laura M. Sly Canada Laura M. Sly's profile →
Citations per field
00.5×1.5×
Laura M. Sly · 1×
Citations per year

Countries citing papers authored by Mirjam Schenk

Since Specialization
Citations

This map shows the geographic impact of Mirjam Schenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Schenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Schenk more than expected).

Fields of papers citing papers by Mirjam Schenk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam Schenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Schenk. The network helps show where Mirjam Schenk may publish in the future.

Co-authorship network of co-authors of Mirjam Schenk

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam Schenk. A scholar is included among the top collaborators of Mirjam Schenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam Schenk. Mirjam Schenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 7
4 6
5 23
6 44
7 31
8 40
9 17
10 56
11 24
12 296
13 39
14 100
15 87
16 91
17 7
18 100
19 58
20 97

About Mirjam Schenk

Mirjam Schenk is a scholar working on Immunology, Oncology and Biological Psychiatry, having authored 38 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Immune Response and Inflammation (10 papers) and Immune Cell Function and Interaction (8 papers). The work is most often cited by research in Immunology (1.7k citations), Infectious Diseases (590 citations) and Pathology and Forensic Medicine (358 citations). Mirjam Schenk has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Christoph Mueller, Robert L. Modlin, Axel Bouchon, Genhong Cheng, Frank Seibold, Rosane M. B. Teles, Delphine J. Lee, Stephan R. Krutzik, Hassan Sadozai and Philip T. Liu. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026